MedTrace Logo

Prevalence and Serotype of Streptococcus Pneumoniae Hospitalized Adult With Community-Acquired Pneumonia

NCT05173727 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 355

Last updated 2023-12-12

No results posted yet for this study

Summary

Streptococcus Pneumoniae is one of the etiology in severe CAP and accounts for about 60-75% of cases and is likely to be the leading cause of unknown etiologic pneumonia. In Indonesia, studies regarding the prevalence of Streptococcus pneumoniae as the cause of CAP are still very rare. Therefore, there is still a need for further investigation in S. pneumoniae prevalence among hospitalized CAP by utilizing different detection methods in Indonesia. Antibiotics as a therapy of CAP also showed high levels of resistance, meanwhile, early detection of causative pathogen is potentially reducing the incidence of antibiotic resistance and usage of broad-spectrum antibiotics.

Conditions

  • Pneumonia, Bacterial

Sponsors & Collaborators

  • Eijkman Institute for Molecular Biology

    collaborator OTHER

  • Dr Cipto Mangunkusumo General Hospital

    lead OTHER

Principal Investigators

  • Gurmeet Singh, MD, PhD · Indonesian Society of Respirology

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-05-15
Primary Completion
2023-07-15
Completion
2023-11-01

Countries

  • Indonesia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05173727 on ClinicalTrials.gov